# BMPR2 Mutations and Iron Metabolism in Pulmonary Arterial Hypertension

> **NCT04086537** · — · COMPLETED · sponsor: **Heidelberg University** · enrollment: 109 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DIAGNOSTIC_TEST:** hepcidin levels and BMPR2 expression

## Key facts

- **NCT ID:** NCT04086537
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-02
- **Primary completion:** 2020-01-31
- **Final completion:** 2021-02-28
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2021-04-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04086537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04086537, "BMPR2 Mutations and Iron Metabolism in Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04086537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*